Dysfunction of Glia-Neuron Communication in Pathophysiology of Schizophrenia

被引:64
作者
Hashimoto, Kenji [1 ]
Shimizu, Eiji [1 ]
Iyo, Masaomi [1 ]
机构
[1] Chiba Univ Grad Sch Med, Dept Psychiat, 1-8-1 Inohana, Chiba 2608670, Japan
关键词
NMDA receptor; growth factors; neurotrophic factors; cytokines; D-serine; schizophrenia;
D O I
10.2174/1573400054065569
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Multiple lines of evidence suggest that genetic factors and environmental factors as well as a dysfunction in the glutamatergic neurotransmission contribute to the pathophysiology of schizophrenia. Communication between neurons and glia is essential for axonal conduction, synaptic neurotransmission, and information processing, and thus is required for normal functioning of the nervous system during development and throughout adult life. A number of studies have demonstrated that the substances which communicate between neurons and glia are altered in the blood, cerebrospinal fluid (CSF), and postmortem brain samples of schizophrenic patients. These findings suggest that neuron-glia communication might be impaired in the brains of schizophrenic patients. In this article, we review the imbalance of neuron-glia communication presented in the neurodevelopmental hypothesis as well as the glutamate hypothesis of schizophrenia. First, we discuss the role of growth factors (e.g., basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), midkine), brain-derived neurotrophic factor (BDNF) and cytokines in the pathophysiology of schizophrenia. Second, we focus on the role of endogenous substances (glutamate, glutamine, D-serine, kynurenic acid, and glutathione), which modulate the NMDA receptor function, in the pathophysiology of schizophrenia.
引用
收藏
页码:151 / 163
页数:13
相关论文
共 168 条
[1]   Schizophrenia, sensory gating, and nicotinic receptors [J].
Adler, LE ;
Olincy, A ;
Waldo, M ;
Harris, JG ;
Griffith, J ;
Stevens, K ;
Flach, K ;
Nagamoto, H ;
Bickford, P ;
Leonard, S ;
Freedman, R .
SCHIZOPHRENIA BULLETIN, 1998, 24 (02) :189-202
[2]   Serum levels of soluble IL-2 receptor α, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration [J].
Akiyama, K .
SCHIZOPHRENIA RESEARCH, 1999, 37 (01) :97-106
[3]   Targeted deletion of the kynurenine aminotransferase II gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via α7 nicotinic receptors in the hippocampus [J].
Alkondon, M ;
Pereira, EFR ;
Yu, P ;
Arruda, EZ ;
Almeida, LEF ;
Guidetti, P ;
Fawcett, WP ;
Sapko, MT ;
Randall, WR ;
Schwarcz, R ;
Tagle, DA ;
Albuquerque, EX .
JOURNAL OF NEUROSCIENCE, 2004, 24 (19) :4635-4648
[4]  
ALLEN RM, 1978, AM J PSYCHIAT, V135, P1081
[5]   Schizophrenia: the fundamental questions [J].
Andreasen, NC .
BRAIN RESEARCH REVIEWS, 2000, 31 (2-3) :106-112
[6]   Association of EGF polymorphism with schizophrenia in Finnish men [J].
Anttila, S ;
Illi, A ;
Kampman, O ;
Mattila, KM ;
Lehtimäki, T ;
Leinonen, E .
NEUROREPORT, 2004, 15 (07) :1215-1218
[7]  
Aschner M, 2000, NEUROTOXICOLOGY, V21, P1101
[8]   Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs [J].
Bai, O ;
Chlan-Fourney, J ;
Bowen, R ;
Keegan, D ;
Li, XM .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 71 (01) :127-131
[9]  
Bartha R, 1997, ARCH GEN PSYCHIAT, V54, P959
[10]   In vivo nuclear magnetic resonance studies of glutamate-γ-aminobutyric acid-glutamine cycling in rodent and human cortex:: the central role of glutamine [J].
Behar, KL ;
Rothman, DL .
JOURNAL OF NUTRITION, 2001, 131 (09) :2498S-2504S